Wall Street Zen Upgrades Mettler-Toledo International (NYSE:MTD) to “Buy”

Mettler-Toledo International (NYSE:MTD) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

MTD has been the subject of a number of other reports. Wells Fargo & Company boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Stifel Nicolaus lifted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price for the company in a research report on Monday, December 15th. Citigroup lifted their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Finally, The Goldman Sachs Group started coverage on Mettler-Toledo International in a research report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $1,435.42.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,362.59 on Friday. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,525.17. The company has a market capitalization of $27.70 billion, a price-to-earnings ratio of 32.35, a price-to-earnings-growth ratio of 2.86 and a beta of 1.42. The company’s 50-day simple moving average is $1,416.03 and its two-hundred day simple moving average is $1,364.45.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The company’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period last year, the firm earned $12.41 earnings per share. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Equities analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In related news, insider La Guerroniere Marc De sold 6,055 shares of the company’s stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total transaction of $9,010,929.90. Following the completion of the sale, the insider directly owned 187 shares in the company, valued at $278,289.66. This represents a 97.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 236 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the transaction, the insider directly owned 159 shares of the company’s stock, valued at $225,554.22. This trade represents a 59.75% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 9,116 shares of company stock worth $13,473,111. Insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Elyxium Wealth LLC acquired a new stake in shares of Mettler-Toledo International during the 4th quarter valued at $29,000. Versant Capital Management Inc boosted its stake in shares of Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 8 shares in the last quarter. SJS Investment Consulting Inc. grew its holdings in shares of Mettler-Toledo International by 2,700.0% during the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 27 shares during the last quarter. NewSquare Capital LLC increased its stake in shares of Mettler-Toledo International by 94.4% in the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares during the period. Finally, MV Capital Management Inc. raised its holdings in Mettler-Toledo International by 50.0% in the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.